No Data
No Data
Gelonghui Fund Daily Report | Public fund baijiu holdings have dropped to as low as 10%! Wan Minyuan increased holdings.
Focus on the latest news in the fund.
Nanmo Biotech (688265.SH): Repurchased 0.4082 million shares of the company's stock for the first time.
On July 29th, Gelunhui announced that on July 29th, 2024, the company repurchased 0.408244 million shares of the company for the first time through the Shanghai Stock Exchange trading system by centralized bidding, accounting for 0.5236% of the company's total share capital of 77,963,513 shares. The minimum price of the repurchase transaction was 21.37 yuan/share, and the highest price was 22.50 yuan/share. The total amount of funds paid was 9.082418 million yuan (excluding transaction fees such as taxes and transaction commissions).
Nanmo Biotech (688265.SH) plans to repurchase its shares at a cost of 15 to 30 million yuan.
On July 25th, Gelonhui reported that Nammu Biology (688265.SH) plans to buy back shares for an amount not less than RMB 15 million and not more than RMB 30 million, with a share buyback price not exceeding RMB 32 per share, in order to maintain the company's value and shareholder equity.
Shanghai Model Organisms Center CFO Steps Down
Nanmo Biotech (688265.SH): The repurchase period has expired and a total of 1.0119% of the company's shares have been repurchased
Gelonghui, May 22丨Nanmo Biotech (688265.SH) announced that as of May 22, 2024, the company's share repurchase period has expired, and the implementation of the share repurchase plan has been completed. The company bought back 788,912 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 1.0119% of the company's total share capital of 77,963,513 shares. The highest price of the repurchase transaction was 29.98 yuan/share, the lowest price was 23.90 yuan/share, and the total capital paid was RMB 21.453.59 million (excluding taxes, transaction commissions, etc.)
Nanmo Biotech (688265.SH): Repurchase 1.0119% of shares through centralized bidding
Gelonghui, May 7, 丨 Nanmo Biotech (688265.SH) announced that as of April 30, 2024, the company had repurchased 788,912 shares through the Shanghai Stock Exchange trading system, accounting for 1.0119% of the company's total share capital of 77,963,513 shares. The highest price of the repurchase transaction was 29.98 yuan/share, the lowest price was 23.90 yuan/share, and the total amount of capital paid was RMB 21.453.59 million (excluding transaction fees such as taxes and transaction fees).
No Data